Liver transplant patients face hidden fatty liver risk
NCT ID NCT07204600
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study will track 100 liver transplant patients to see how many develop a new fatty liver condition called MASLD after their transplant. Researchers will also look for risk factors like weight, diabetes, and cholesterol levels. The goal is to better understand this common but often overlooked complication.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this study could help doctors identify liver transplant patients at high risk for developing new fatty liver disease, leading to better monitoring and early treatment.
- What could go wrong
- This is an observational study that does not test a new treatment. It only measures how common the condition is, so it won't directly lead to a cure or therapy.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DE NOVO METABOLIC DYSFUNCTION-ASSOCIATED STEATOTIC LIVER DISEASE (MASLD) POST LIVER TRANSPLANT are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.